Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies).
Leuk Res. 2010 Jul;34(7):864-70. doi: 10.1016/j.leukres.2009.12.004. Epub 2010 Feb 2.
Leuk Res. 2010.
PMID: 20129667
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases.
Itzykson R, Ayari S, Vassilief D, Berger E, Slama B, Vey N, Suarez F, Beyne-Rauzy O, Guerci A, Cheze S, Thomas X, Stamatoullas A, Gardembas M, Bauduer F, Kolb A, Chaury MC, Legros L, Damaj G, Chermat F, Dreyfus F, Fenaux P, Ades L; Groupe Francophone des Myelodysplasies (GFM).
Itzykson R, et al. Among authors: vassilief d.
Leukemia. 2009 Apr;23(4):673-8. doi: 10.1038/leu.2008.362. Epub 2009 Jan 8.
Leukemia. 2009.
PMID: 19151787
Clinical Trial.
Item in Clipboard
A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies.
Bouscary D, Legros L, Tulliez M, Dubois S, Mahe B, Beyne-Rauzy O, Quarre MC, Vassilief D, Varet B, Aouba A, Gardembas M, Giraudier S, Guerci A, Rousselot P, Gaillard F, Moreau A, Rousselet MC, Ifrah N, Fenaux P, Dreyfus F; Groupe Français des Myélodysplasies (GFM).
Bouscary D, et al. Among authors: vassilief d.
Br J Haematol. 2005 Dec;131(5):609-18. doi: 10.1111/j.1365-2141.2005.05817.x.
Br J Haematol. 2005.
PMID: 16351636
Free article.
Clinical Trial.
Item in Clipboard
Effectiveness and tolerance of low to very low dose thalidomide in low-risk myelodysplastic syndromes.
Tamburini J, Elie C, Park S, Beyne-Rauzy O, Gardembas M, Berthou C, Mahe B, Sanhes L, Stamatoullas A, Vey N, Aouba A, Slama B, Quesnel B, Vekhoff A, Sotto JJ, Vassilief D, Al-Nawakil C, Fenaux P, Dreyfus F, Bouscary D; Groupe Francophone des Myélodysplasies, GFM.
Tamburini J, et al. Among authors: vassilief d.
Leuk Res. 2009 Apr;33(4):547-50. doi: 10.1016/j.leukres.2008.06.005. Epub 2008 Jul 21.
Leuk Res. 2009.
PMID: 18640718
Clinical Trial.
No abstract available.
Item in Clipboard
Aplastic anemia responsive to cyclosporine complicating the evolution of polycythemia vera.
Bouscary D, Jondeau K, Viguié F, Zompi S, Fontenay-Roupie M, Quarre MC, Vassilief D, Dreyfus F, Casadevall N.
Bouscary D, et al. Among authors: vassilief d.
Leuk Lymphoma. 1999 May;33(5-6):607-11. doi: 10.3109/10428199909058468.
Leuk Lymphoma. 1999.
PMID: 10342591
Item in Clipboard
Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications.
Magli-Barioz D, Ounnoughène N, Paugy P, Quarrè MC, Vassilief D, Lopez I, Goudemand J, Negrier C, Assogba U, Driss F, Dumont MA, Molho P.
Magli-Barioz D, et al. Among authors: vassilief d.
Haemophilia. 2004 Sep;10(5):572-81. doi: 10.1111/j.1365-2516.2004.00930.x.
Haemophilia. 2004.
PMID: 15357786
Item in Clipboard
Unusual occurrence of spontaneous haematomas in three asymptomatic HIV-infected haemophilia patients a few days after the onset of ritonavir treatment.
Ginsburg C, Salmon-Ceron D, Vassilief D, Rabian C, Rotschild C, Fontenay-Roupie M, Stieltjes N, Sicard D.
Ginsburg C, et al. Among authors: vassilief d.
AIDS. 1997 Mar;11(3):388-9.
AIDS. 1997.
PMID: 9147435
No abstract available.
Item in Clipboard
Cite
Cite